Background: Tamaka Shwasa , a chronic respiratory condition described in Ayurveda , shares significant clinical resemblance with bronchial asthma. Modern pharmacological approaches offer symptomatic relief but may involve recurrence and side effects. Ayurvedic Shodhana therapies like Virechana Karma and herbal interventions such as Devdarvadi Kwatha are mentioned for their potential in breaking the Samprapti (pathogenesis) of the disease. Aims and Objectives: The aims and objectives of this study are to evaluate the efficacy of Virechana Karma followed by oral administration of Devdarvadi Kwatha in children diagnosed with Tamaka Shwasa . Materials and Methodology: An open single-arm clinical study was conducted at the Department of Kaumarbhritya, involving 50 pediatric patients diagnosed with Tamaka Shwasa . After Deepana Pachana with Chitrakadi vati and Snehapana with Go Ghrita , Virechana was administered using Trivrit Avaleha . Post Shodhana , patients received Devdarvadi Kwatha orally for 14 days. Outcome measures included clinical parameters such as frequency and severity of Shwasa Vega , frequency of attacks, global initiative for asthma asthma control score, peak expiratory flow rate (PEFR), forced expiratory volume in 1 s, and forced vital capacity. Results: Statistically significant improvement ( P < 0.001) was observed in major symptoms, including Ghurghuraka , Kasa , and Shwasa Vega . PEFR readings improved from an average baseline of 166.5 L/min–221.5 L/min postintervention. No adverse effects were reported during the course of the treatment. Conclusion: The combined approach of Virechana Karma followed by Devdarvadi Kwatha offers effective management of Tamaka Shwasa in children. The results support the classical hypothesis of breaking the Dosha-Vega-Samprapti through Shodhana and Shamana therapy.
Yadav et al. (Wed,) studied this question.